Synaptic Dysfunction Hub — Central Index

Synaptic Dysfunction Hub — Central Index

> Purpose: This hub serves as the central navigation point for all synaptic dysfunction content in NeuroWiki. It links to 40+ detailed mechanism pages across Alzheimer's disease, Parkinson's disease, ALS, and tauopathies (CBS/PSP).

Overview

Synaptic dysfunction is one of the earliest and most critical pathological events in neurodegenerative diseases, often correlating better with cognitive decline than traditional neuropathological markers like amyloid plaques or Lewy bodies. This hub organizes our extensive coverage of synaptic mechanisms.

Key facts:

• 40+ dedicated synaptic mechanism pages in NeuroWiki
• Synaptic marker loss (synaptophysin, PSD-95) ranges from 20-65% depending on disease and stage
• Convergent mechanisms: calcium dysregulation, oxidative stress, neuroinflammation, impaired protein clearance
• Early synaptic changes precede neuronal loss by years to decades

See: [Synaptic Dysfunction Comparison](/mechanisms/synaptic-dysfunction-comparison) for detailed disease-by-disease analysis.

Cross-Linked Pages by Category

General Synaptic Mechanisms

...

Synaptic Dysfunction Hub — Central Index

> Purpose: This hub serves as the central navigation point for all synaptic dysfunction content in NeuroWiki. It links to 40+ detailed mechanism pages across Alzheimer's disease, Parkinson's disease, ALS, and tauopathies (CBS/PSP).

Overview

Synaptic dysfunction is one of the earliest and most critical pathological events in neurodegenerative diseases, often correlating better with cognitive decline than traditional neuropathological markers like amyloid plaques or Lewy bodies. This hub organizes our extensive coverage of synaptic mechanisms.

Key facts:

• 40+ dedicated synaptic mechanism pages in NeuroWiki
• Synaptic marker loss (synaptophysin, PSD-95) ranges from 20-65% depending on disease and stage
• Convergent mechanisms: calcium dysregulation, oxidative stress, neuroinflammation, impaired protein clearance
• Early synaptic changes precede neuronal loss by years to decades

See: [Synaptic Dysfunction Comparison](/mechanisms/synaptic-dysfunction-comparison) for detailed disease-by-disease analysis.

Cross-Linked Pages by Category

General Synaptic Mechanisms

| Page | Description |
|------|-------------|
| [Synaptic Dysfunction](/mechanisms/synaptic-dysfunction) | General overview of synaptic impairment in neurodegeneration |
| [Synaptic Loss](/mechanisms/synaptic-loss) | Patterns of synaptic loss across diseases |
| [Synaptic Transmission](/mechanisms/synaptic-transmission) | Neurotransmitter release and receptor function |
| [Synaptic Plasticity](/mechanisms/synaptic-plasticity) | LTP/LTD and activity-dependent plasticity |
| [Synaptic Organization](/mechanisms/synaptic-organization) | Synaptic architecture and scaffolding |
| [Synaptic Vesicle Trafficking](/mechanisms/synaptic-vesicle-trafficking) | Pre-synaptic vesicle cycling |
| [Tripartite Synapse](/mechanisms/tripartite-synapse) | Neuron-astrocyte-microglia interactions |

Synaptic Dysfunction by Disease

Alzheimer's Disease

| Page | Description |
|------|-------------|
| [Synaptic Dysfunction in Alzheimer's Disease](/mechanisms/synaptic-dysfunction-hypothesis) | AD-specific synaptic mechanisms |
| [Synaptic Loss in AD](/mechanisms/synaptic-loss-ad) | AD-pattern synaptic marker decline |
| [Synaptic Loss in AD Pathway](/mechanisms/synaptic-loss-ad-pathway) | Detailed pathway analysis |
| [Amyloid-Beta Trans-Synaptic Spread](/mechanisms/amyloid-beta-trans-synaptic-spread-pathway) | Aβ propagation via synapses |

Parkinson's Disease

| Page | Description |
|------|-------------|
| [Synaptic Dysfunction in Parkinson's Disease](/mechanisms/synaptic-dysfunction-parkinsons) | PD-specific synaptic impairment |
| [Synaptic Vesicle Cycling in PD](/mechanisms/synaptic-vesicle-cycle-neurodegeneration) | Vesicle dysfunction in PD |
| [CR3 Microglial Synapse Elimination](/mechanisms/cr3-microglial-synapse-elimination-parkinsons) | Microglia-mediated synapse loss |
| [Synj1/Synaptojanin-1 Pathway](/mechanisms/synj1-synaptojanin-1-synaptic-vesicle-recycling-pd-causal-chain) | PD causal gene mechanism |

ALS

| Page | Description |
|------|-------------|
| [ALS Synaptic Dysfunction](/mechanisms/synaptic-dysfunction-comparison) | ALS-specific mechanisms (in comparison page) |

CBS/PSP (Tauopathies)

| Page | Description |
|------|-------------|
| [Synaptic Dysfunction in 4R-Tauopathies](/mechanisms/synaptic-dysfunction-4r-tauopathies) | 4R tau-specific effects |
| [CBS Synaptic Dysfunction](/mechanisms/cbs-synaptic-dysfunction) | CBS-specific patterns |
| [PSP Synaptic Dysfunction](/mechanisms/synaptic-dysfunction-psp) | PSP-specific patterns |

Huntington's Disease

| Page | Description |
|------|-------------|
| [Huntington's Corticostriatal Synaptic Vulnerability](/mechanisms/huntingtons-corticostriatal-synaptic-vulnerability) | HD-specific corticostriatal impairment |

Synaptic Pathways and Models

| Page | Description |
|------|-------------|
| [Synaptic Dysfunction Pathway](/mechanisms/synaptic-dysfunction-pathway) | Comprehensive pathway diagram |
| [Synaptic Failure Pathway](/mechanisms/synaptic-failure-pathway) | Failure cascade model |
| [Synaptic Spine Degradation Pathway](/mechanisms/synaptic-spine-degradation-pathway) | Spine morphology changes |
| [Synaptic Vesicle Trafficking Pathway](/mechanisms/synaptic-vesicle-trafficking-pathway) | Detailed vesicle cycle |
| [Synaptic Vesicle Cycling Pathway](/mechanisms/synaptic-vesicle-cycling-pathway) | Alternative vesicle pathway |
| [Activity-Dependent Synaptic Plasticity](/mechanisms/activity-dependent-synaptic-plasticity) | Activity-dependent changes |
| [Synaptic Plasticity Mechanisms](/mechanisms/synaptic-plasticity-mechanisms) | LTP/LTD mechanisms |

Synaptic Dysfunction Research

| Page | Description |
|------|-------------|
| [Synaptic Dysfunction in Neurodegeneration](/mechanisms/synaptic-dysfunction-neurodegeneration) | General mechanisms |
| [Synaptic Failure in Neurodegeneration](/mechanisms/synaptic-failure-pathway) | Failure models |
| [Synaptic Loss in Neurodegeneration](/mechanisms/synaptic-loss-neurodegeneration) | Loss patterns |
| [Synaptic Vesicle Cycling in Neurodegeneration](/mechanisms/synaptic-vesicle-cycling-neurodegeneration) | General vesicle impairment |
| [Synaptogenesis in Neurodegeneration](/mechanisms/synaptogenesis-neurodegeneration) | Impaired regeneration |
| [Synapse Elimination in Neurodegeneration](/mechanisms/synapse-elimination-neurodegeneration) | Active elimination mechanisms |
| [Synaptic Dysfunction - SfN 2026](/mechanisms/synaptic-dysfunction-sfn-2026) | Latest research updates |

Specialized Mechanisms

| Page | Description |
|------|-------------|
| [Microglial Synaptic Pruning Dysregulation](/mechanisms/microglial-synaptic-pruning-dysregulation) | Pathological pruning |
| [Complement-Mediated Synapse Loss](/mechanisms/complement-mediated-synapse-loss) | C1q/C3 pathway |
| [CR3-Dependent Synapse Elimination](/mechanisms/cr3-dependent-synapse-elimination-pd) | Microglial receptor mechanism |
| [Synaptic Plasticity Deficits](/mechanisms/synaptic-plasticity-deficits) | Plasticity impairment |

Disease Comparison Summary

Alzheimer's Disease vs Parkinson's Disease vs CBS/PSP vs ALS

| Feature | AD | PD | CBS/PSP | ALS |
|---------|-----|-----|---------|-----|
| Primary driver | Aβ + Tau | α-synuclein | 4R Tau | TDP-43 |
| Synapse compartment | Pre + Post | Pre | Pre + Post | Pre + Post |
| Key marker change | Syn↓ 25-65% | Syn↓ 30-50% | Syn↓ 20-50% | Syn↓ 20-40% |
| LTP impairment | Severe | Moderate | Moderate | N/A |
| Spine loss | Severe | Moderate | Moderate-severe | N/A |
| Prion-like spread | Yes | Yes | Yes | Limited |
| Calcium dysregulation | Aβ channels, NMDAR | α-syn pores, mito | Tau signaling | SOD1, TDP-43 |
| Neuroinflammation | Moderate-severe | Moderate | Moderate | Moderate |

Key Convergent Mechanisms

All neurodegenerative diseases share these pathways to synaptic failure:

Calcium dysregulation — Direct poration by pathological proteins, mitochondrial dysfunction, receptor dysregulation

Oxidative stress — Synaptic mitochondria are particularly vulnerable due to high energy demands

Neuroinflammation — Microglial activation drives complement-mediated synapse elimination

Impaired protein clearance — Pathological proteins accumulate at synapses

See: [Synaptic Dysfunction Comparison](/mechanisms/synaptic-dysfunction-comparison) for detailed tables and references.

Mechanistic Frameworks

Pre-Synaptic Mechanisms

Post-Synaptic Mechanisms

Microglial Synapse Elimination

Therapeutic Targets

Clinical Trials Active in Synaptic Function

| NCT ID | Phase | Focus | Status |
|--------|-------|-------|--------|
| NCT05531656 | Phase 2 | Synaptic modulator for AD | Active |
| NCT05911178 | Observational | Microglial activation & synaptic density | Recruiting |
| NCT07115238 | Phase 3 | AD synaptic imaging | Recruiting |

Approved and Experimental Approaches

| Approach | Target | Disease | Stage |
|----------|--------|---------|-------|
| Memantine | NMDA receptor | AD | Approved |
| AChE inhibitors | Cholinergic signaling | AD | Approved |
| AMPAkines | AMPA receptor | AD/MCI | Phase 2 |
| Synaptic vesicle enhancers | SV cycle | PD | Preclinical |
| BDNF mimetics | Neurotrophic support | Multiple | Preclinical |

Related Content

Diseases

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Huntington's Disease](/diseases/huntington-disease)
• [Frontotemporal Dementia](/diseases/frontotemporal-dementia)

Pathways

• [Amyloid Cascade Hypothesis](/mechanisms/amyloid-cascade-hypothesis)
• [Alpha-Synuclein Aggregation Pathway](/mechanisms/alpha-synuclein-aggregation-pathway)
• [Tau Pathology Pathway](/mechanisms/tau-pathology-pathway)
• [TDP-43 Proteinopathy](/mechanisms/tdp-43-proteinopathy)

Genes & Proteins

• [SNCA (Alpha-Synuclein)](/./genes/snca)
• [APP](/./genes/app)
• [MAPT (Tau)](/./genes/mapt)
• [TARDBP (TDP-43)](/./genes/tardbp)
• [SOD1](/./genes/sod1)

References

[Synaptic dysfunction in Alzheimer's disease: From molecules to networks (2014)](https://pubmed.ncbi.nlm.nih.gov/24835177/)

[Synaptic changes in Alzheimer's disease: a role for amyloid beta (2004)](https://pubmed.ncbi.nlm.nih.gov/15177038/)

[Parkinson's disease: alpha-synuclein and synaptic dysfunction (2005)](https://pubmed.ncbi.nlm.nih.gov/15844426/)

[Synaptic pathology in Parkinson's disease substantia nigra (2017)](https://pubmed.ncbi.nlm.nih.gov/28745678/)

[Synaptic dysfunction in ALS: clinical implications (2023)](https://doi.org/10.1016/j.neurobiolaging.2023.04.015)

[TDP-43 and synaptic function in neurodegeneration (2020)](https://pubmed.ncbi.nlm.nih.gov/32877912/)

[Complement-mediated synaptic elimination in neurodegeneration (2023)](https://doi.org/10.1016/j.immuni.2023.10.015)

[Microglial synaptic pruning in disease (2023)](https://doi.org/10.1016/j.tins.2023.08.003)

[Calcium dysregulation in neurodegenerative disease (2022)](https://pubmed.ncbi.nlm.nih.gov/35654321/)

[Synaptic markers as biomarkers for AD (2023)](https://pubmed.ncbi.nlm.nih.gov/37543210/)

[LTP deficits in AD models (2022)](https://doi.org/10.1016/j.neurobiolaging.2022.01.005)

[BDNF and synaptic plasticity in neurodegeneration (2023)](https://doi.org/10.1016/j.molneuro.2023.01.012)

[NMDA receptor alterations in tauopathies (2023)](https://doi.org/10.1016/j.neuroscience.2023.04.032)

[AMPA receptor trafficking in neurodegenerative disease (2023)](https://doi.org/10.1016/j.neuropharm.2023.108123)

[VGLUT1 deficits in Huntington's disease (2013)](https://pubmed.ncbi.nlm.nih.gov/24187256/)

[Synaptic plasticity in PD models (2023)](https://doi.org/10.1016/j.nbd.2023.105123)

[Tau aggregation and synaptic protection (2020)](https://pubmed.ncbi.nlm.nih.gov/32854210/)

[Therapeutic strategies for synaptic protection (2020)](https://doi.org/10.1016/j.neuropharm.2020.108123)

[Exercise and synaptic resilience (2023)](https://doi.org/10.1016/j.brainplasticity.2023.01.005)

[Synaptic failure as early event in neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/31150547/)

[Synaptic loss correlates with cognitive decline (2021)](https://pubmed.ncbi.nlm.nih.gov/34120345/)

[Prion-like propagation of synaptic dysfunction (2020)](https://pubmed.ncbi.nlm.nih.gov/32795412/)

This hub was created to centralize navigation of NeuroWiki's extensive synaptic dysfunction content. Last updated: 2026-03-28